These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Lipoprotein(a) in postmenopausal women: assessment of cardiovascular risk and therapeutic options. Anagnostis P; Karras S; Lambrinoudaki I; Stevenson JC; Goulis DG Int J Clin Pract; 2016 Dec; 70(12):967-977. PubMed ID: 28032426 [TBL] [Abstract][Full Text] [Related]
6. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women. Bayrak A; Aldemir DA; Bayrak T; Corakçi A; Dursun P Arch Gynecol Obstet; 2006 Aug; 274(5):289-96. PubMed ID: 16810536 [TBL] [Abstract][Full Text] [Related]
7. Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy. Kim CJ; Min YK; Ryu WS; Kwak JW; Ryoo UH Arch Intern Med; 1996 Aug 12-26; 156(15):1693-700. PubMed ID: 8694668 [TBL] [Abstract][Full Text] [Related]
9. Does the type of hormone replacement therapy affect lipoprotein (a), homocysteine, and C-reactive protein levels in postmenopausal women? Bukowska H; Stanosz S; Zochowska E; Millo B; Sieja K; Chełstowski K; Naruszewicz M Metabolism; 2005 Jan; 54(1):72-8. PubMed ID: 15562383 [TBL] [Abstract][Full Text] [Related]
10. Lipoprotein(a) risk in women and efficacy of ascorbate. Bostom AG JAMA; 1994 Oct; 272(15):1169. PubMed ID: 7933344 [No Abstract] [Full Text] [Related]
11. Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause. Shlipak MG; Simon JA; Vittinghoff E; Lin F; Barrett-Connor E; Knopp RH; Levy RI; Hulley SB JAMA; 2000 Apr; 283(14):1845-52. PubMed ID: 10770146 [TBL] [Abstract][Full Text] [Related]
12. Postmenopausal hormone-replacement therapy, plasma lipoprotein[a], and risk for coronary heart disease. Gotto AM J Lab Clin Med; 1994 Jun; 123(6):800-3. PubMed ID: 8201254 [No Abstract] [Full Text] [Related]
13. Lipoprotein(a): medical treatment options for an elusive molecule. Parhofer KG Curr Pharm Des; 2011; 17(9):871-6. PubMed ID: 21476974 [TBL] [Abstract][Full Text] [Related]
14. The effect of hormone replacement therapy and tibolone on lipoprotein (a) concentrations in postmenopausal women: A systematic review and meta-analysis. Anagnostis P; Galanis P; Chatzistergiou V; Stevenson JC; Godsland IF; Lambrinoudaki I; Theodorou M; Goulis DG Maturitas; 2017 May; 99():27-36. PubMed ID: 28364865 [TBL] [Abstract][Full Text] [Related]
15. Effect of oral estradiol on Lp(a) and other lipoproteins in postmenopausal women. A randomized, double-blind, placebo-controlled, crossover study. Haines C; Chung T; Chang A; Masarei J; Tomlinson B; Wong E Arch Intern Med; 1996 Apr; 156(8):866-72. PubMed ID: 8774205 [TBL] [Abstract][Full Text] [Related]
16. Plasma lipids, lipoprotein Lp(a), apolipoproteins, and hemostatic risk factors distributions in postmenopausal women. Cubrilo-Turek M; Stavljenić-Rukavina A; Reiner Z; Zrinski R Acta Med Croatica; 1999; 53(2):61-6. PubMed ID: 10705622 [TBL] [Abstract][Full Text] [Related]
17. Management of hypercholesterolaemia in postmenopausal women. Davidson MH; Maki KC; Karp SK; Ingram KA Drugs Aging; 2002; 19(3):169-78. PubMed ID: 12027776 [TBL] [Abstract][Full Text] [Related]
18. Modification of the lipidic and coagulative pattern in postmenopause women: effect of hormone replacement therapy. Evola G; Novo G; Amoroso G; Guttilla D; Lo Coco L; Guagliardo M; Lupo A; Averna MR; Giambanco V; Miller V; Novo S Int Angiol; 2010 Aug; 29(4):355-61. PubMed ID: 20671654 [TBL] [Abstract][Full Text] [Related]
19. An examination of the effect of combined cyclical hormone replacement therapy on lipoprotein(a) and other lipoproteins. Haines CJ; Chung TK; Masarei JR; Tomlinson B; Lau JT Atherosclerosis; 1996 Jan; 119(2):215-22. PubMed ID: 8808498 [TBL] [Abstract][Full Text] [Related]